CVS Health Corp
CVS74.430USD
+0.430+0.58%
Fechamento 09/18, 16:00（ET）Cotações atrasadas em 15 min
94.30BValor de mercado
20.81P/L TTM
Mais detalhes de CVS Health Corp Empresa
CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.
Informações da empresa
Código da empresaCVS
Nome da EmpresaCVS Health Corp
Data de listagemOct 01, 1952
CEOMr. J. David Joyner
Número de funcionários300000
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 01
EndereçoOne Cvs Dr.
CidadeWOONSOCKET
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02895
Telefone14017651500
Sitehttps://cvshealth.com/
Código da empresaCVS
Data de listagemOct 01, 1952
CEOMr. J. David Joyner
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
47.18K
-21.39%
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
12.01K
+15.04%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
4.28K
+94.41%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Director
Director
4.28K
+94.41%
Mr. Roger N. Farah
Mr. Roger N. Farah
Executive Chairman of the Board
Executive Chairman of the Board
4.12K
-92.40%
Ms. Alecia A. DeCoudreaux, J.D.
Ms. Alecia A. DeCoudreaux, J.D.
Independent Director
Independent Director
2.97K
--
Dr. Amy L. Compton-Phillips, M.D.
Dr. Amy L. Compton-Phillips, M.D.
Executive Vice President and Chief Medical Officer
Executive Vice President and Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Larry Robbins
Mr. Larry Robbins
Independent Director
Independent Director
11.95M
--
Mr. Tilak Mandadi
Mr. Tilak Mandadi
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
Executive Vice President, Chief Data, Digital, Analytics and Technology Officer
47.18K
-21.39%
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Lead Independent Director
Lead Independent Director
45.91K
+0.31%
Mr. Steven H. Nelson
Mr. Steven H. Nelson
Executive Vice President and President - Aetna
Executive Vice President and President - Aetna
21.33K
--
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Independent Director
Independent Director
12.01K
+15.04%
Mr. Douglas H. (Doug) Shulman, J.D.
Mr. Douglas H. (Doug) Shulman, J.D.
Independent Director
Independent Director
4.28K
+94.41%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Pharmacy
52.51B
55.51%
Premiums
32.82B
34.70%
Front Store
5.24B
5.54%
Other
3.50B
3.70%
Net investment income(loss)
520.00M
0.55%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pharmacy
52.51B
55.51%
Premiums
32.82B
34.70%
Front Store
5.24B
5.54%
Other
3.50B
3.70%
Net investment income(loss)
520.00M
0.55%
Distribuição de ações
Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.44%
Dodge & Cox
5.78%
Capital World Investors
5.28%
BlackRock Institutional Trust Company, N.A.
5.01%
State Street Global Advisors (US)
4.64%
Outro
69.85%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.44%
Dodge & Cox
5.78%
Capital World Investors
5.28%
BlackRock Institutional Trust Company, N.A.
5.01%
State Street Global Advisors (US)
4.64%
Outro
69.85%
Tipos de investidores
Investidores
Proporção
Investment Advisor
46.32%
Investment Advisor/Hedge Fund
30.08%
Hedge Fund
3.46%
Research Firm
2.64%
Pension Fund
2.01%
Bank and Trust
1.83%
Sovereign Wealth Fund
1.66%
Individual Investor
1.06%
Insurance Company
0.10%
Outro
10.84%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
3697
1.12B
88.15%
+11.64M
2025Q1
3787
1.12B
88.80%
+14.13M
2024Q4
3853
1.08B
85.46%
-1.57M
2024Q3
3812
1.05B
83.30%
-34.78M
2024Q2
3834
1.06B
84.02%
-4.44M
2024Q1
3863
1.03B
82.03%
-36.45M
2023Q4
3882
1.05B
81.65%
-1.13M
2023Q3
3770
1.04B
80.61%
-13.78M
2023Q2
3775
1.03B
80.60%
-13.09M
2023Q1
3785
1.03B
80.72%
-44.48M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
117.73M
9.31%
+968.46K
+0.83%
Mar 31, 2025
Dodge & Cox
73.46M
5.81%
+3.35M
+4.78%
Mar 31, 2025
Capital World Investors
68.40M
5.41%
+7.36M
+12.06%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
64.96M
5.13%
+4.87M
+8.11%
Mar 31, 2025
State Street Global Advisors (US)
57.99M
4.58%
+1.04M
+1.82%
Mar 31, 2025
Fidelity Management & Research Company LLC
24.22M
1.91%
+3.08M
+14.57%
Mar 31, 2025
Geode Capital Management, L.L.C.
27.96M
2.21%
+907.87K
+3.36%
Mar 31, 2025
Capital International Investors
26.19M
2.07%
-478.74K
-1.80%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
18.70M
1.48%
+3.80M
+25.51%
Dec 31, 2024
Pzena Investment Management, LLC
17.68M
1.4%
-1.93M
-9.83%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
iShares U.S. Healthcare Providers ETF
15.6%
Invesco S&P Ultra Dividend Revenue ETF
6.31%
VanEck Retail ETF
4.95%
Davis Select US Equity ETF
4.75%
Coastal Compass 100 ETF
4.7%
Simplify Health Care ETF
4.15%
iShares US Consumer Staples ETF
4.07%
Monarch Volume Factor Dividend Tree Index ETF
3.73%
Invesco S&P 500 Pure Value ETF
3.52%
First Trust Consumer Staples Alphadex Fund
3.51%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção15.6%
Invesco S&P Ultra Dividend Revenue ETF
Proporção6.31%
VanEck Retail ETF
Proporção4.95%
Davis Select US Equity ETF
Proporção4.75%
Coastal Compass 100 ETF
Proporção4.7%
Simplify Health Care ETF
Proporção4.15%
iShares US Consumer Staples ETF
Proporção4.07%
Monarch Volume Factor Dividend Tree Index ETF
Proporção3.73%
Invesco S&P 500 Pure Value ETF
Proporção3.52%
First Trust Consumer Staples Alphadex Fund
Proporção3.51%
Dividendo
Um total de
14.66B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 03, 2025
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025
Jan 23, 2025
Feb 03, 2025
Jan 23, 2025
Sep 19, 2024
CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024
Oct 21, 2024
Nov 01, 2024
Oct 21, 2024
Jul 08, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024
Jul 22, 2024
Aug 01, 2024
Jul 22, 2024
Mar 21, 2024
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024
Apr 22, 2024
May 01, 2024
Apr 19, 2024
Dec 06, 2023
CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024
Jan 22, 2024
Feb 01, 2024
Jan 19, 2024
Sep 21, 2023
CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 01, 2023
Oct 19, 2023
Jul 07, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 01, 2023
Jul 20, 2023
Mar 16, 2023
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 01, 2023
Apr 20, 2023
Dec 15, 2022
CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 01, 2023
Jan 19, 2023
Sep 21, 2022
CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 01, 2022
Oct 20, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
